Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation - 18/09/19
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 12 |
| Iconographies | 8 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Background |
Disulfiram (DSF) is a drug used for treatment of alcoholism that has also displayed promising anti-cancer activity. It unfolds its effects by inhibiting the enzyme activity of aldehyde dehydrogenase (ALDH) isoforms.
Methods |
MTT assay, spheroid formation, clonogenicity assay, qRT-PCR, and ALDH enzyme activity analysis were performed using ovarian cancer cell lines IGROV1, SKOV3 and SKOV3IP1. Cell cycle analyses and measurement of intracellular reactive oxygen species (ROS) were carried out by flow cytometry. ALDH+ and ALDH− cells were isolated by FACS sorting.
Results |
ALDH activity was inhibited in ovarian cancer stem cells (the proportion of ALDH+ cells was reduced from 21.7% to 0.391%, 8.4% to 0%, 6.88% to 0.05% in cell lines IGROV1, SKOV3, and SKOV3IP1, respectively). DSF with or without the cofactor copper (Cu2+) exhibited cytotoxicity dose- and time-dependent and enhanced cisplatin-induced apoptosis. DSF + Cu2+ increased intracellular ROS levels triggering apoptosis of ovarian cancer stem cells (CSC). Significantly more colony and spheroid formation was observed in ALDH+ compared with ALDH- cells (P < 0.01). Moreover, ALDH+ cells were more resistant to cisplatin treatment compared with ALDH-cells (P < 0.05) and also exhibited a lower basal level of ROS. However, no significant difference in ROS accumulation nor in cellular viability was observed in ALDH + cells in comparison to ALDH- cells after pre-treatment with DSF (0.08 μM).
Conclusion |
Our findings provide evidence that DSF might be employed as a novel adjuvant chemotherapeutic agent in combination with cisplatin for treatment of ovarian cancer.
Le texte complet de cet article est disponible en PDF.Keywords : Adjuvant chemotherapy, ALDH enzyme activity, Cellular apoptosis, Cytotoxicity, Novel chemotherapeutic agent
Plan
Vol 118
Article 109371- octobre 2019 Retour au numéro
Article précédent
- The effect of topical ramipril and losartan cream in inhibiting scar formation
- Bin Zheng, Qing-Qing Fang, Xiao-Feng Wang, Bang-Hui Shi, Wan-Yi Zhao, Chun-Ye Chen, Min-Xia Zhang, Li-Yun Zhang, Yan-Yan Hu, Peng Shi, Lie Ma, Wei-Qiang Tan
- Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway
- Tengyang Ni, Haibo Wang, Dan Li, Li Tao, Mengying Lv, Feng Jin, Weimin Wang, Jun Feng, Yayun Qian, Masataka Sunagawa, Yanqing Liu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?